158 related articles for article (PubMed ID: 17520405)
1. Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia.
Ayhan A; Guven ES; Guven S; Sakinci M; Dogan NU; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(6):715-9. PubMed ID: 17520405
[TBL] [Abstract][Full Text] [Related]
2. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate.
Cattaneo A; Carli P; De Marco A; Sonni L; Bracco G; De Magnis A; Taddei GL
J Reprod Med; 1996 Feb; 41(2):99-102. PubMed ID: 8656422
[TBL] [Abstract][Full Text] [Related]
3. Response of vulvar lichen sclerosus and squamous cell hyperplasia to graduated topical steroids.
Clark TJ; Etherington IJ; Luesley DM
J Reprod Med; 1999 Nov; 44(11):958-62. PubMed ID: 10589407
[TBL] [Abstract][Full Text] [Related]
4. Lichen sclerosus. Therapy with clobetasol propionate.
Lorenz B; Kaufman RH; Kutzner SK
J Reprod Med; 1998 Sep; 43(9):790-4. PubMed ID: 9777618
[TBL] [Abstract][Full Text] [Related]
5. Does treatment of vulvar lichen sclerosus influence its prognosis?
Cooper SM; Gao XH; Powell JJ; Wojnarowska F
Arch Dermatol; 2004 Jun; 140(6):702-6. PubMed ID: 15210461
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation.
Bracco GL; Carli P; Sonni L; Maestrini G; De Marco A; Taddei GL; Cattaneo A
J Reprod Med; 1993 Jan; 38(1):37-40. PubMed ID: 8441129
[TBL] [Abstract][Full Text] [Related]
7. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease.
Renaud-Vilmer C; Cavelier-Balloy B; Porcher R; Dubertret L
Arch Dermatol; 2004 Jun; 140(6):709-12. PubMed ID: 15210462
[TBL] [Abstract][Full Text] [Related]
8. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus.
Bornstein J; Heifetz S; Kellner Y; Stolar Z; Abramovici H
Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):80-4. PubMed ID: 9465808
[TBL] [Abstract][Full Text] [Related]
9. [Our experience in treating vulvar lichen sclerosus].
Cattani P; Manfrin E; Presti F; Sartori R; Buffo L
Minerva Ginecol; 1997 May; 49(5):207-12. PubMed ID: 9304081
[TBL] [Abstract][Full Text] [Related]
10. Malignant potential of mixed vulvar dystrophy (lichen sclerosus associated with squamous cell hyperplasia).
Rodke G; Friedrich EG; Wilkinson EJ
J Reprod Med; 1988 Jun; 33(6):545-50. PubMed ID: 3404517
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and histopathologic picture of lichen sclerosus treated with clobetasol propionate].
Rotsztejn H; Krawczyk T; Nadel I; Połać I; Tchórzewski H; Pertyński T
Pol Merkur Lekarski; 1999 Nov; 7(41):224-5. PubMed ID: 10680456
[TBL] [Abstract][Full Text] [Related]
12. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
Goldstein AT; Marinoff SC; Christopher K
J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
[TBL] [Abstract][Full Text] [Related]
13. Lichen sclerosus and squamous hyperplasia of the vulva. A clinical study of medical treatment.
Cattaneo A; Bracco GL; Maestrini G; Carli P; Taddei GL; Colafranceschi M; Marchionni M
J Reprod Med; 1991 Apr; 36(4):301-5. PubMed ID: 2072362
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl.
Goldstein AT; Marinoff SC; Christopher K
J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):35-7. PubMed ID: 15010037
[TBL] [Abstract][Full Text] [Related]
15. [Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region].
Cattaneo A; De Marco A; Sonni L; Bracco GL; Carli P; Taddei GL
Minerva Ginecol; 1992 Nov; 44(11):567-71. PubMed ID: 1480305
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of vulvar lichen sclerosus in a general gynecology practice.
Goldstein AT; Marinoff SC; Christopher K; Srodon M
J Reprod Med; 2005 Jul; 50(7):477-80. PubMed ID: 16130842
[TBL] [Abstract][Full Text] [Related]
17. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus.
Smith YR; Quint EH
Obstet Gynecol; 2001 Oct; 98(4):588-91. PubMed ID: 11576572
[TBL] [Abstract][Full Text] [Related]
18. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study.
Jones RW; Sadler L; Grant S; Whineray J; Exeter M; Rowan D
J Reprod Med; 2004 Oct; 49(10):808-11. PubMed ID: 15568404
[TBL] [Abstract][Full Text] [Related]
19. [Vulvar squamous cell hyperplasia and lichen sclerosus et atrophicus: clinical picture, morphology and treatment].
Rotsztejn H; Krawczyk T; Bartodziej U
Ginekol Pol; 1998 Feb; 69(2):67-72. PubMed ID: 9591383
[TBL] [Abstract][Full Text] [Related]
20. Topical mometasone furoate for vulvar lichen sclerosus.
Cattaneo A; De Magnis A; Botti E; Sonni L; Carli P; Taddei GL
J Reprod Med; 2003 Jun; 48(6):444-8. PubMed ID: 12856516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
